MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
2022: On Jan. 13, 2021, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Abbott Rapid Dx North America, LLC, iHealth Lab Inc., and Roche Diagnostics Corporation to purchase total of 380 million over-the-counter COVID-19 test kits.
F. Hoffmann-La Roche Holding Ltd (RHHBF; RHHBY)
Organization & Developments: Roche
Parents
F. Hoffmann-La Roche Holding Ltd (RHHBF; RHHBY)
Children
*Developments: Roche
*Developments: Roche (Archives 2010-2014)
*Developments: Roche (Archives 2015-2016)
*Organization: Roche
*Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.
*Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
*Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS.
*Roche: R&D and Business Developments
*Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
2011: PTC Therapeutics has agreed to a licensing deal with Swiss pharmaceutical firm Roche for its spinal muscular atrophy program
2017: More Positives For Roche, The Core Biotech For The Long Run - Roche Holding Ltd ADR (OTCMKTS:RHHBY)
2017: Roche and Ignyta Reach Definitive Merger Agreement
2017: Roche gets FDA nod for Zika-screening blood test
2017: Senseonics keeps busy with Europe launch, Roche partnerships while FDA wait continues
2017: VA_65--667-18-1-045-0001 FY 18 Roche Diagnostic Accu-Check supplies - VA256-17-AP-10562
2017: VA_65--Roche CoaguChek at the SFVA and CBOCs Point of Care Coagulation using a CLIA waived handheld device that will interface with the VA Lab Information System (VISTA)
2017: VA_65--Roche Diabetes Care V797D-50597 May 15, 2016
2017: VA_65--Roche/Ventana Stain Systems Reagent/Chemical Solutions One-year Requirements Contract
2017: VA_66--Notice of Intent to Sole Source-FSS BPA Roche laboratory supplies
2017: VA_66--Notice of Intent-Sole Source IDIQ Roche laboratory supplies
2017: VA_66--Roche Diagnostics Co COBAS Ampliprep/Cobas Taqman HCV V.2.0 Kit
2017: VA_70--Roche Coag CoaguChek Annual License
2017: VA_J--Nexes Strainer (Lab) - Annual Service/Support (Lab)
2018: Roche dumps 4 eye, CNS and cancer drugs in Q4 clear-out
2018: The Hunt For Cancer Vaccines - How Roche May Win Big (Part 1 Of 2)_seekingalpha.com
2019: Roche Finishes Year With Big Deals, Gene Therapy In Focus As Competition Heats Up_seekingalpha.com
2019: Roche signs up Dicerna in a $200M-plus cash alliance to help develop a hep B cocktail, capping biotech’s big year – Endpoints News
2019: Roche, Senseonics extend diabetes monitor distribution deal to BRIC countries
2019: Roche's Kadcyla Approval Will Have A Big Impact On Breast Cancer Patients_seekingalpha.com
2019: Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures_www.investors.com
2020: JPM: Roche, Illumina unveil 15-year cancer diagnostic tie-up
2020: Roche's COVID-19 antibody test nets FDA emergency authorization
2020: Unfazed by PhII miss, Roche ushers Prothena's Parkinson's drug into late-stage trial
2021: Cambridge Quantum to Develop Quantum Algorithms with Roche for Drug Discovery & Development – Cambridge Quantum Computing
2021: Cancer giant Roche splashes into cell therapy with $3B+ Adaptimmune deal for off-the-shelf drugs
2021: Roche to use quantum computing for drug discovery_fortune.com
2022: Roche Holdings AG Basel ADR Common Stock (RHHBY) Investor Presentation - Slideshow_ seekingalpha.com
2022: Roche Needs Some Wins_seekingalpha.com
2023: New effort aims to build an African ancestry biobank_ axios
2024: Alzheimer's blood test from Roche, Eli Lilly nabs FDA breakthrough tag
2024: More Of The Same Isn't Good Enough For Roche
2024: Roche to take on Abbott, Dexcom with its first CGM
2024: Roche weighs whether speedy approval path is open for latest Alzheimer’s drug
2024: Roche: Currency Headwinds Are Masking Strong Growth Trends
2024: Roche: Currency Headwinds Are Masking Strong Growth Trends
2024: Roche: Obesity Treatment's Promise Isn't Enough
2024: Roche: Strong Long-Term Potential Overshadowed
2024: Roche: The Devil Is In The Details - Obesity Data Presentation Disappoints_seekingalpha.com
2024: Roche: Value Remains Despite Covid-19 Revenue Growth Loss
2024: UCB's tau drug flunks phase 2 Alzheimer's trial days after Roche's exit from $120M bet
2025: Blood Tests for Alzheimer’s Are Here
2025: Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics
2025: Roche Executing Commercially, But R&D Productivity Remains A Work In Progress_seekingalpha.com
2025: Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win_seekingalpha.com
2025: Roche Holding AG 2024 Q4 - Results - Earnings Call Presentation
2025: Roche posts trial data for breast cancer drug giredestrant
2025: Roche Q4 Earnings Review: Solid All-Court Performance, But Quiet On GLP-1 Progress
2025: Roche: Sustainable Sales Growth, Margin Leverage, And Supportive Late-Stage Pipeline
2026: Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Ke
COBAS BKV
COBAS EBV
ELECSYS B-AMYLOID (1-42) CSF II
ELECSYS PHOSPHO-TAU (181P) CSF
FOUNDATIONONE LIQUID CDX
Genentech, United States, is a wholly owned member of the Roche Group.
Hoffman-LaRoche, Ltd
Roche Diagnostics
Roche Products (Ireland) Ltd
Roche Venture Fund
Jumps
*Key People: Roche
Finance & Acquisitions: Roche